Delivery rate, transdermal drug

Ointments, creams, and plasters are used for transdermal drug delivery. In the latter case, sustained release is accomplished by diffusion from a reservoir through a microporous membrane and into the skin [26,48,49]. Iontophoresis and electroporation has been reported to successfully promote transdermal delivery rates [50-52]. 

It has been recognized that transdermal rate-controlled drug delivery offers one or more of the following potential benefits ... 

Because of the large surface area of the skin and its bypass of the liver as a first pass step in metabolism, many drug delivery systems have been developed that control the rate of drug delivery to the skin for subsequent absorption. Effective transdermal drug delivery systems of this type deliver uniform quantities of drug to the skin over a period of time. Technically, transdermal drug delivery systems may be classified into monolithic and membrane-controlled systems (9). 

As indicated in Fig. 1, a transdermal iontophoretic system requires that two electrode assemblies contact the patient s skin. The donor electrode (also known as the delivery or active electrode) contacts the drug reservoir. The counter electrode (also known as the return or receptor electrode) contacts the counter reservoir and completes the electrical circuit by providing a path for the current. The two reservoirs are separated from each other and contact skin over a fixed area. The electrodes apply an electric field across the skin by converting electric current supplied by the battery into ionic current moving in the skin and body. In doing so, a Faradaic reaction takes place at the electrode/ electrolyte interface. As described previously in this chapter, there is generally a linear dependence of the rate of drug delivery on this current. 

Drugs chosen for delivery via a transdermal drug-delivery system must adequately penetrate the skin in such a way that the system determines the delivery rate that should be fairly constant. In addition, the drug must not irritate or sensitize the skin. It is hoped that in the future more drugs will be developed for transdermal delivery. This could become an alternative route for drug delivery to children who have difficulty with oral administration. 

---